Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Z Potter

Showing results (61-70 of 225) with videos related to

Pageof 23
Sort By:
Journal of Clinical Psychopharmacology|April 1, 1985
Interethnic dissociation between debrisoquine and desipramine hydroxylationM V Rudorfer, E A Lane, W Z Potter
The Psychiatric Clinics of North America|September 1, 1984
Second-generation antidepressantsM V Rudorfer, R N Golden, W Z Potter
Advances in Biochemical Psychopharmacology|January 1, 1984
Active metabolites of antidepressants: pharmacodynamics and relevant pharmacokineticsW Z Potter, M V Rudorfer, E A Lane
European Journal of Pharmacology|August 11, 1989
Ten day administration of desipramine produces an increase in KL/KH for beta-receptors in rat hippocampusJ Turkka, G Gurguis, W Z Potter, et al.
Archives of General Psychiatry|December 1, 1985
Plasma norepinephrine level in affective disorders. Relationship to melancholiaA Roy, D Pickar, M Linnoila, et al.
Psychopharmacology Bulletin|July 1, 1978
Prediction of steady state plasma concentration of imipramine [proceedings]W Z Potter, A P Zavadil, F K Goodwin
The American Journal of Psychiatry|August 1, 1983
Reliability of urinary monoamine and metabolite output measurements in depressed patientsM Linnoila, F Karoum, T Miller, et al.
Psychopharmacology Bulletin|January 1, 1991
Dosage regimen design for cyclic antidepressants: a review of pharmacokinetic methodsC L DeVane, M V Rudorfer, W Z Potter
Psychopharmacology|January 1, 1993
Dose-dependent effects of intravenous alprazolam on neuroendocrine, biochemical, cardiovascular, and behavioral parameters in humansO T Osman, J K Hsiao, W Z Potter
Clinical Neuropharmacology|January 1, 1992
Steady-state predictions based on first dose dataW Z Potter, C L DeVane, M V Rudorfer
Pageof 23

Showing results (61-70 of 225) with videos related to

Sort By:
Pageof 23
Journal of Clinical Psychopharmacology|April 1, 1985
Interethnic dissociation between debrisoquine and desipramine hydroxylationM V Rudorfer, E A Lane, W Z Potter
The Psychiatric Clinics of North America|September 1, 1984
Second-generation antidepressantsM V Rudorfer, R N Golden, W Z Potter
Advances in Biochemical Psychopharmacology|January 1, 1984
Active metabolites of antidepressants: pharmacodynamics and relevant pharmacokineticsW Z Potter, M V Rudorfer, E A Lane
European Journal of Pharmacology|August 11, 1989
Ten day administration of desipramine produces an increase in KL/KH for beta-receptors in rat hippocampusJ Turkka, G Gurguis, W Z Potter, et al.
Archives of General Psychiatry|December 1, 1985
Plasma norepinephrine level in affective disorders. Relationship to melancholiaA Roy, D Pickar, M Linnoila, et al.
Psychopharmacology Bulletin|July 1, 1978
Prediction of steady state plasma concentration of imipramine [proceedings]W Z Potter, A P Zavadil, F K Goodwin
The American Journal of Psychiatry|August 1, 1983
Reliability of urinary monoamine and metabolite output measurements in depressed patientsM Linnoila, F Karoum, T Miller, et al.
Psychopharmacology Bulletin|January 1, 1991
Dosage regimen design for cyclic antidepressants: a review of pharmacokinetic methodsC L DeVane, M V Rudorfer, W Z Potter
Psychopharmacology|January 1, 1993
Dose-dependent effects of intravenous alprazolam on neuroendocrine, biochemical, cardiovascular, and behavioral parameters in humansO T Osman, J K Hsiao, W Z Potter
Clinical Neuropharmacology|January 1, 1992
Steady-state predictions based on first dose dataW Z Potter, C L DeVane, M V Rudorfer
Pageof 23